The use of PAMG-1 testing in patients with preterm labor, intact membranes and a short sonographic cervix reduces the rate of unnecessary antenatal glucocorticoid administration.
Sven KehlChristel WeissJutta PretscherFriederike BaierFlorian FaschingbauerMatthias W BeckmannFlorian Matthias StumpfePublished in: Journal of perinatal medicine (2021)
Addition of biomarker testing can help to avoid unnecessary ACS administrations in women with shortened cervical length.